What it is
Peptides acting on it
Evidence
[literature]Retatrutide’s glucagon-driven lipolysis/energy-expenditure arm helped deliver up to 28.3% Phase 3 weight loss (TRIUMPH-1, 2026) — beyond appetite-suppression-only GLP-1 agents. — SOURCE-retatrutide-triumph1-phase3